Global life science player
Defined the European M&A strategy (individual targets to consider, initiated first contact) for a global life science company (Market cap > $30 bn) interested in entering an adjacent space.
Global Pharma player
Reviewed the US strategy and pipeline for a global pharma player that was contemplating increasing its US presence in one segment of the market.
Global Vaccine player
Performed commercial due diligence on behalf of a large Investment Fund that was looking to invest in the segment.
MedTech Player in Western Europe
Animal Health Go-to-Market Strategy for a Med Device company with an innovative technology for treating wounds and soft tissue/skin conditions.
Biologics player in North America
Investor Memorandum for series B financing for an innovative biologics player in North America targeting some of the most damaging pathogens in animals.
Biotech player in Western Europe
Animal Health Strategic Plan and Investment Memorandum for an innovative biotech player in Western Europe (the company subsequently received investor funding).
Pharmaco in Western Europe
Growth Strategy for a sizeable pharmaco (Sales >$1 bn) in Western Europe with the view to get the company ready for IPO.
Pharma CSO in Western Europe
M&A strategy (including targets to consider/disregard, timeline of acquisition) for a large pharma CSO in Western Europe.
Outsourcing Co in Western Europe
Organisational Structure (both corporate and local organisations in the key markets) for a large pharma outsourcing company with a view to optimally support strategy execution.
Pharma Wholesaler in Western Europe
Assessment of the overall healthcare landscape in Benelux and Nordics and optimal route to market in these geographies for a sizeable pharma wholesaler (Sales >$1 bn) in WE.
Oncology player in Asia Pacific
Partnering strategy and screening for potential development and commercialisation partners for an Asia-Pacific company with a Phase II asset.
Nutraceutical company in Central Europe
Strategic Review for an innovative Nutraceutical/ Nutrigenomics player in Central Europe, Investment Memorandum and support to secure investor funding.
Global MedTech Company
Strategic Review (overall strategic targets, breakdown for divisions and countries) for a global MedTech player (Market cap > $12 bn and Sales > $3 bn).
Global Diagnostics Player
Supported a global diagnostics player to screen, evaluate and execute (including in integration) two large acquisitions.
Global Med Device Company
Organisational Structure (both corporate and local organisations in the key markets) for a global Med Device company.
Global Diagnostics Player
Project Management to coordinate a dedicated market access initiative of a global diagnostics player into a Central European market.
MedTech Accelerator in Western Europe
Defined the overall vision, strategy and investment case for a MedTech player to shift from a one product line company to a Med Tech accelerator for innovative technologies.
MedTech Player in Western Europe
Product Strategy for 3 new innovative technologies (including detailed financials forecasts, route to market, exit options, investors pitch) for a MedTech player.